Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults

Author: Chichester Jessica A.   Jones R. Mark   Green Brian J.   Stow Mark   Miao Fudu   Moonsammy George   Streatfield Stephen J.   Yusibov Vidadi  

Publisher: MDPI

E-ISSN: 1999-4915|4|11|3227-3244

ISSN: 1999-4915

Source: Viruses, Vol.4, Iss.11, 2012-11, pp. : 3227-3244

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content